1. Byrne, CD., Targher, G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47-S64.doi:10.1016/j.jhep.2014.12.012 25920090
Google Scholar | Crossref | Medline2. VanWagner, LB., Rinella, ME. Extrahepatic manifestations of nonalcoholic fatty liver disease. Curr Hepatol Rep. 2016;15(2):75-85.doi:10.1007/s11901-016-0295-9 27218012
Google Scholar | Crossref | Medline3. Lamprea-Montealegre, JA., Shlipak, MG., Estrella, MM. Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention. Heart. 2021;107(16):1282-1288.doi:10.1136/heartjnl-2020-318004 33568433
Google Scholar | Crossref | Medline4. Levey, AS., Stevens, LA., Schmid, CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.doi:10.7326/0003-4819-150-9-200905050-00006 19414839
Google Scholar | Crossref | Medline | ISI5. Stevens, LA., Coresh, J., Greene, T., Levey, AS. Assessing kidney function — measured and estimated glomerular filtration rate. N Engl J Med. 2006;354(23):2473-2483.doi:10.1056/NEJMra054415 16760447
Google Scholar | Crossref | Medline | ISI6. Taylor, W., Gladman, D., Helliwell, P et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006;54(8):2665-2673.doi:10.1002/art.21972 16871531
Google Scholar | Crossref | Medline7. Girman, CJ., Rhodes, T., Mercuri, M et al. The metabolic syndrome and risk of major coronary events in the Scandinavian simvastatin survival study (4S) and the air Force/Texas coronary atherosclerosis prevention study (AFCAPS/TexCAPS. Am J Cardiol. 2004;93(2):136-141.doi:10.1016/j.amjcard.2003.09.028 14715336
Google Scholar | Crossref | Medline8. Mehta, SR., Thomas, EL., Bell, JD., Johnston, DG., Taylor-Robinson, SD. Non-invasive means of measuring hepatic fat content. World J Gastroenterol. 2008;14(22):3476-3483.doi:10.3748/wjg.14.3476 18567074
Google Scholar | Crossref | Medline9. Chalasani, N., Younossi, Z., Lavine, JE et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American gastroenterological association, American association for the study of liver diseases, and American College of gastroenterology. Gastroenterology. 2012;142(7):1592-1609.doi:10.1053/j.gastro.2012.04.001 22656328
Google Scholar | Crossref | Medline | ISI10. Ogdie, A., Grewal, SK., Noe, MH et al. Risk of incident liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a population-based study. J Invest Dermatol. 2018;138(4):760-767.doi:10.1016/j.jid.2017.10.024 29104161
Google Scholar | Crossref | Medline11. Roberts, KK., Cochet, AE., Lamb, PB et al. The prevalence of NAFLD and NASH among patients with psoriasis in a tertiary care dermatology and rheumatology clinic. Aliment Pharmacol Ther. 2015;41(3):293-300.doi:10.1111/apt.13042 25521607
Google Scholar | Crossref | Medline12. Targher, G., Bertolini, L., Rodella, S et al. Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative/laser-treated retinopathy in type 2 diabetic patients. Diabetologia. 2008;51(3):444-450.doi:10.1007/s00125-007-0897-4 18058083
Google Scholar | Crossref | Medline13. Targher, G., Chonchol, M., Zoppini, G., Abaterusso, C., Bonora, E. Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: is there a link? J Hepatol. 2011;54(5):1020-1029.doi:10.1016/j.jhep.2010.11.007 21145850
Google Scholar | Crossref | Medline14. Gisondi, P., Targher, G., Zoppini, G., Girolomoni, G. Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009;51(4):758-764.doi:10.1016/j.jhep.2009.04.020 19560226
Google Scholar | Crossref | Medline15. Miele, L., Vallone, S., Cefalo, C et al. Prevalence, characteristics and severity of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis. J Hepatol. 2009;51(4):778-786.doi:10.1016/j.jhep.2009.06.008 19664838
Google Scholar | Crossref | Medline16. van der Voort, EAM., Koehler, EM., Dowlatshahi, EA et al. Psoriasis is independently associated with nonalcoholic fatty liver disease in patients 55 years old or older: results from a population-based study. J Am Acad Dermatol. 2014;70(3):517-524.doi:10.1016/j.jaad.2013.10.044 24373781
Google Scholar | Crossref | Medline17. Carrascosa, JM., Bonanad, C., Dauden, E., Botella, R., Olveira-Martín, A. En nombre del Grupo de Trabajo en Inflamación Sistémica en psoriasis. psoriasis and nonalcoholic fatty liver disease. Actas Dermosifiliogr. 2017;108:506-514.
Google Scholar | Crossref | Medline18. Maza, A., Montaudié, H., Sbidian, E et al. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis. J Eur Acad Dermatol Venereol. 2011;25(Suppl. 2):19-27.doi:10.1111/j.1468-3083.2011.03992.x 21388455
Google Scholar | Crossref | Medline19. Chadban, SJ., Barraclough, KA., Campbell, SB et al. KHA-CARI guideline: KHA-CARI adaptation of the KDIGO clinical practice guideline for the care of kidney transplant recipients. Nephrol. 2012;17(3):204-214.doi:10.1111/j.1440-1797.2011.01559.x 22212251
Google Scholar | Crossref | Medline20. Le Boëdec, M., Marhadour, T., Devauchelle-Pensec, V et al. Baseline laboratory test abnormalities are common in early arthritis but rarely contraindicate methotrexate: study of three cohorts (ESPOIR, VErA, and Brittany). Semin Arthritis Rheum. 2013;42(5):474-481.doi:10.1016/j.semarthrit.2012.08.001 23352246
Google Scholar | Crossref | Medline21. Capalbo, O., Giuliani, S., Ferrero-Fernández, A., Casciato, P., Musso, CG. Kidney-liver pathophysiological crosstalk: its characteristics and importance. Int Urol Nephrol. 2019;51(12):2203-2207.doi:10.1007/s11255-019-02288-x 31549285
Google Scholar | Crossref | Medline22. Li, Y., Liu, L., Wang, B., Wang, J., Chen, D. Simple steatosis is a more relevant source of serum inflammatory markers than omental adipose tissue. Clin Res Hepatol Gastroenterol. 2014;38(1):46-54.doi:10.1016/j.clinre.2013.08.006 24075193
Google Scholar | Crossref | Medline23. Małgorzewicz, S., Skrzypczak-Jankun, E., Jankun, J. Plasminogen activator inhibitor-1 in kidney pathology (review). Int J Mol Med. 2013;31(3):503-510.doi:10.3892/ijmm.2013.1234 23314920
Google Scholar | Crossref | Medline24. Musso, G., Gambino, R., Tabibian, JH et al. Association of non-alcoholic fatty liver disease with chronic kidney disease: a systematic review and meta-analysis. PLoS Med. 2014;11(7):e1001680. doi:10.1371/journal.pmed.1001680
Google Scholar | Crossref | Medline25. Kanbay, M., Bulbul, MC., Copur, S et al. Therapeutic implications of shared mechanisms in non-alcoholic fatty liver disease and chronic kidney disease. J Nephrol. 2021;34(3):649-659.doi:10.1007/s40620-020-00751-y 32440840
Google Scholar | Crossref | Medline26. Wan, J., Wang, S., Haynes, K., Denburg, MR., Shin, DB., Gelfand, JM. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ. 2013;347(oct15 7):f5961. doi:10.1136/bmj.f5961 24129480
Google Scholar | Crossref | Medline27. Garcia-Doval, I., Carretero, G., Vanaclocha, F et al. Risk of serious adverse events associated with biologic and nonbiologic psoriasis systemic therapy: patients ineligible vs eligible for randomized controlled trials. Arch Dermatol. 2012;148(4):463-470.doi:10.1001/archdermatol.2011.2768 22508869
Google Scholar | Crossref | Medline28. Ungprasert, P., Raksasuk, S. Psoriasis and risk of incident chronic kidney disease and end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol. 2018;50(7):1277-1283.doi:10.1007/s11255-018-1868-z 29644523
Google Scholar | Crossref | Medline29. Özyilmaz, A., de Jong, PE., Gansevoort, RT. Screening for chronic kidney disease can be of help to prevent atherosclerotic end-organ damage. Nephrol Dial Transplant. 2012;27(11):4046-4052.doi:10.1093/ndt/gfs438 23144071
Google Scholar | Crossref | Medline30. Kitching, AR., Holdsworth, SR. The emergence of TH17 cells as effectors of renal injury. J Am Soc Nephrol. 2011;22(2):235-238.doi:10.1681/ASN.2010050536 21289213
Google Scholar | Crossref | Medline